THR Global
Community Perspectives
Independent articles and perspectives from contributors across the tobacco harm reduction community. THR Global provides this directory and links to each author's original publication.
Apply to contributeArticles remain the work of their individual authors. Inclusion in this directory does not mean THR Global endorses every view expressed.
Community PerspectivesConsumer Perspectives
9 November 2026
This study begins with a familiar tobacco-control proposition: vaping among young people has increased partly because of pervasive and aggressive advertising.
Alan Gorley • Consumer Perspectives • Australia
Community PerspectivesConsumer Perspectives
8 November 2026
There is an important question at the centre of the #DigitalMob study: what kinds of commercial messages are reaching Aboriginal Australians in their everyday digital lives?
Alan Gorley • Consumer Perspectives • Australia
Community PerspectivesRegional Perspectives
6 November 2026
Fourteen years without smoking, thousands of dollars saved, and what the economics of tobacco harm reduction reveal about public-health success.
Alan Gorley • Regional Perspectives • Australia
Community PerspectivesRegional Perspectives
4 November 2026
Two new Australian papers arrive at a very neat conclusion: Western Australia has a large number of licensed tobacco retailers, those retailers are more concentrated in disadvantaged areas, various licensing restrictions could dramatically reduce their numbers, and most surveyed Western Australians say tobacco should be less available.
Alan Gorley • Regional Perspectives • Australia
Community PerspectivesConsumer Perspectives
4 November 2026
This paper has an important idea at its centre, but I think the authors take it one step too far.
Alan Gorley • Consumer Perspectives • Australia
Community PerspectivesPolicy & Regulation
3 November 2026
What changes when we judge tobacco policy by the cigarettes people actually stop smoking?
Alan Gorley • Policy & Regulation • Australia
Community PerspectivesConsumer Perspectives
29 October 2026
Janet Hoek’s account of illicit tobacco reveals people under financial pressure. Her proposed response gives too little scrutiny to the policies they are struggling against.
Alan Gorley • Consumer Perspectives • Australia
Community PerspectivesConsumer Perspectives
28 October 2026
https://onlinelibrary.wiley.com/doi/10.1111/dar.70258
Alan Gorley • Consumer Perspectives • Australia
Community PerspectivesScience & Evidence
23 October 2026
Part I: no evidence of measurable “third hand” effects in environments where children live
Roberto Sussman • Science & Evidence • Mexico
Community PerspectivesScience & Evidence
23 October 2026
Seventeen vapers, a snapshot of vascular function, and a conclusion about harm reduction that reaches beyond the study.
Alan Gorley • Science & Evidence • Australia
Community PerspectivesCessation & Behaviour
22 October 2026
Dr. Mercer had answers to my questions!
Skip Murray • Cessation & Behaviour • United States
Community PerspectivesRegional Perspectives
21 October 2026
When smoking estimates diverge, the government owes Australians answers—and people still smoking deserve greater access to harm reduction.
Alan Gorley • Regional Perspectives • Australia
Community PerspectivesRegional Perspectives
20 October 2026
Mark Butler’s incorrect account of tobacco enforcement spending deserves a correction—and a harder debate about what the spending actually achieves.
Alan Gorley • Regional Perspectives • Australia
Community PerspectivesConsumer Perspectives
18 October 2026
11–17 October 2026 - Listening without losing our judgement
Alan Gorley • Consumer Perspectives • Australia
Community PerspectivesScience & Evidence
16 October 2026
Several recent studies claim that quitting with vaping is worse than quitting with other methods. They all have the same critical flaw: confounding by quit duration.
Arielle Selya • Science & Evidence • US
Community PerspectivesRegional Perspectives
16 October 2026
More legal cigarette sales, more Quitline calls and more political accusations do not tell us how many people stopped smoking.
Alan Gorley • Regional Perspectives • Australia
Community PerspectivesConsumer Perspectives
14 October 2026
For years, the debate around vaping has often been dominated by controversy, regulation and fear, but what has sometimes been lost in that argument is the simplest and most important question of all: can vaping help people stop smoking?
Alan Gorley • Consumer Perspectives • Australia
Community PerspectivesPolicy & Regulation
14 October 2026
The FDA updates its Tobacco Products Scientific Advisory Committee (TPSAC) roster.
Skip Murray • Policy & Regulation • United States
Community PerspectivesScience & Evidence
14 October 2026
E-cigs for smoking cessation -- time to share the news
Skip Murray • Science & Evidence • United States
Community PerspectivesConsumer Perspectives
14 October 2026
A credible case for harm reduction must leave room for dependence, uncertainty and uncomfortable truths.
Alan Gorley • Consumer Perspectives • Australia
Community PerspectivesConsumer Perspectives
12 October 2026
The publication date tells us when a paper arrived. It does not necessarily tell us how recently it checked the world.
Alan Gorley • Consumer Perspectives • Australia
Community PerspectivesRegional Perspectives
12 October 2026
When a survey of teenage experimentation becomes an endorsement of Australian nicotine policy.
Alan Gorley • Regional Perspectives • Australia
Community PerspectivesConsumer Perspectives
10 October 2026
4–10 October 2026 | What are we actually measuring?
Alan Gorley • Consumer Perspectives • Australia
Community PerspectivesRegional Perspectives
10 October 2026
Lung Foundation Australia’s survey measures public concern. Its policy conclusions go further than its published questions.
Alan Gorley • Regional Perspectives • Australia
Community PerspectivesConsumer Perspectives
7 October 2026
ACOSH’s joint letter warns against changing tobacco policy.
Alan Gorley • Consumer Perspectives • Australia
Community PerspectivesConsumer Perspectives
5 October 2026
When recovering cigarette sales become a policy trophy, we need to ask whose recovery we are celebrating.
Alan Gorley • Consumer Perspectives • Australia
Community PerspectivesCessation & Behaviour
5 October 2026
On knowing when to pause, when to speak and when to reach out.
Alan Gorley • Cessation & Behaviour • Australia
Community PerspectivesConsumer Perspectives
5 October 2026
My mother was prescribed cigarettes.
N. E. Loucas • Consumer Perspectives • New Zealand
Community PerspectivesPublic Health Debate
4 October 2026
Are adults who smoke the only valid beneficiary of tobacco harm reduction (THR)? A version of my talk at TSRC 2026.
Arielle Selya • Public Health Debate • US
Community PerspectivesScience & Evidence
3 October 2026
My article in the American Council on Science and Health (ACSH)
Arielle Selya • Science & Evidence • US
Community PerspectivesRegional Perspectives
3 October 2026
SHARC’s warning about Australia’s proposed digital duty of care raises a question tobacco harm reduction advocates cannot afford to ignore.
Alan Gorley • Regional Perspectives • Australia
Community PerspectivesRegional Perspectives
1 October 2026
Australia has placed therapeutic vaping inside the pharmacy system. But a legal pathway means little if the person who needs it cannot realistically reach it.
Alan Gorley • Regional Perspectives • Australia
Community PerspectivesRegional Perspectives
30 September 2026
Australia’s tobacco tax policy is built around a simple idea: make cigarettes expensive enough and more people will stop smoking.
Alan Gorley • Regional Perspectives • Australia
Community PerspectivesConsumer Perspectives
27 September 2026
What Numbers, Rules and Good Intentions Miss
Alan Gorley • Consumer Perspectives • Australia
Community PerspectivesConsumer Perspectives
26 September 2026
For years, the youth vaping debate has been framed around a simple objective: reduce vaping.
Alan Gorley • Consumer Perspectives • Australia
Community PerspectivesConsumer Perspectives
25 September 2026
There is something revealing about the way tobacco-control data are sometimes presented.
Alan Gorley • Consumer Perspectives • Australia
Community PerspectivesRegional Perspectives
24 September 2026
Australia embraces harm reduction for people who inject drugs. Why does that principle disappear when the drug is nicotine?
Alan Gorley • Regional Perspectives • Australia
Community PerspectivesRegional Perspectives
23 September 2026
When authorities seize cigarettes or vapes, what happens to the people who were going to buy them?
Alan Gorley • Regional Perspectives • Australia
Community PerspectivesScience & Evidence
20 September 2026
A resource guide for evidence, advocacy, and connection in tobacco, nicotine, and harm reduction
Skip Murray • Science & Evidence • United States
Community PerspectivesScience & Evidence
20 September 2026
There are more and more papers being published that analyze EMR data (especially TriNetX). They suffer from all the usual flaws, plus some unique ones related to severe imprecision in measurement.
Arielle Selya • Science & Evidence • US
Community PerspectivesRegional Perspectives
20 September 2026
A quick apology for the length of this piece, but there is simply a great deal of information to work through if we are going to understand properly what Australia’s 5.8% smoking figure does, and does not, tell us.
Alan Gorley • Regional Perspectives • Australia
Community PerspectivesConsumer Perspectives
18 September 2026
You wake at 6.15 am and automatically reach for the packet beside the bed.
Alan Gorley • Consumer Perspectives • Australia
Community PerspectivesConsumer Perspectives
16 September 2026
When a Charlie Brown event uses smoking-damaged lungs to warn children about vaping
Skip Murray • Consumer Perspectives • United States
Community PerspectivesRegional Perspectives
15 September 2026
Before dismissing regulated retail, walk through the door.
Alan Gorley • Regional Perspectives • Australia
Community PerspectivesRegional Perspectives
14 September 2026
Mark Brooke’s defence of Australian tobacco policy has a credibility problem: the standard of evidence changes depending on whose proposal is being examined.
Alan Gorley • Regional Perspectives • Australia
Community PerspectivesPublic Health Debate
12 September 2026
A high-impact case study in scientific ambiguities, group polarization, and public distrust of health authorities
Arielle Selya • Public Health Debate • US
Community PerspectivesRegional Perspectives
12 September 2026
The Parliamentary Budget Office’s nicotine analysis raises an uncomfortable question: how much of the decline in legal tobacco sales represents quitting, and how much represents shopping elsewhere?
Alan Gorley • Regional Perspectives • Australia
Community PerspectivesRegional Perspectives
12 September 2026
On uncertainty, self-trust, and being human inside a daily routine.
Alan Gorley • Regional Perspectives • Australia
Community PerspectivesRegional Perspectives
10 September 2026
Something strange has happened in New Zealand’s tobacco debate.
Alan Gorley • Regional Perspectives • Australia
Community PerspectivesRegional Perspectives
9 September 2026
There is something rather revealing buried in this Australian adolescent nicotine study.
Alan Gorley • Regional Perspectives • Australia
Community PerspectivesPolicy & Regulation
9 September 2026
Article 5.3 should protect evidence-based policymaking. It should never become a substitute for it.
Alan Gorley • Policy & Regulation • Australia
Community PerspectivesRegional Perspectives
8 September 2026
Australians deserve an honest account of vaping, smoking and policy failure. Hill’s remarks offer selective science and a demand to double down.
Alan Gorley • Regional Perspectives • Australia
Community PerspectivesPolicy & Regulation
7 September 2026
The government demands evidence before changing nicotine policy. Its own documents make the case for applying that standard to the policy already in place.
Alan Gorley • Policy & Regulation • Australia
Community PerspectivesRegional Perspectives
5 September 2026
Selective evidence, unexplained comparisons and a refusal to discuss price incentives make a weak case for preserving Australia’s tobacco settings.
Alan Gorley • Regional Perspectives • Australia
Community PerspectivesPolicy & Regulation
3 September 2026
Chapter Two: Federal Tobacco Taxation: Revenue, Regulation, and Public Health
Skip Murray • Policy & Regulation • United States
Community PerspectivesRegional Perspectives
3 September 2026
The Coalition has proposed a fundamental reset of Australia’s failed nicotine policy. The response from the public health establishment was entirely predictable.
Alan Gorley • Regional Perspectives • Australia
Community PerspectivesPolicy & Regulation
31 August 2026
Australia and New Zealand are separated by a few thousand kilometres of ocean, yet we share medical research, similar health systems and decades of tobacco-control history.
Alan Gorley • Policy & Regulation • Australia
Community PerspectivesConsumer Perspectives
30 August 2026
There is something deeply appealing about a plan.
Alan Gorley • Consumer Perspectives • Australia
Community PerspectivesConsumer Perspectives
30 August 2026
Some conversations end when people say goodbye, and others follow me home.
Alan Gorley • Consumer Perspectives • Australia
Community PerspectivesConsumer Perspectives
29 August 2026
The United States, United Kingdom, Australia and New Zealand are not merely interpreting evidence differently. They are answering different moral questions about commerce, autonomy and acceptable risk
Alan Gorley • Consumer Perspectives • Australia
Community PerspectivesEconomics & Taxation
29 August 2026
There is a remarkable sentence buried near the end of this ABC analysis of Australia’s illicit tobacco crisis:
Alan Gorley • Economics & Taxation • Australia
Community PerspectivesRegional Perspectives
28 August 2026
Senator Dorinda Cox and the Government Senators had an extraordinary body of evidence placed before them during the Senate inquiry into Australia’s illegal tobacco crisis.
Alan Gorley • Regional Perspectives • Australia
Community PerspectivesRegional Perspectives
27 August 2026
There are numbers that should change a public policy debate, and three hundred firebombings are surely one of them.
Alan Gorley • Regional Perspectives • Australia
Community PerspectivesEconomics & Taxation
26 August 2026
Simon Chapman’s latest attack on tobacco excise reform is certainly colourful.
Alan Gorley • Economics & Taxation • Australia
Community PerspectivesScience & Evidence
25 August 2026
A new JAMA article by the Treatment Research Network of SRNT (the Society for Nicotine and Tobacco Research) discusses how clinicians should discuss e-cigarettes with patients who smoke cigarettes.
Arielle Selya • Science & Evidence • US
Community PerspectivesEconomics & Taxation
25 August 2026
Australia should study what worked, then improve it with legal access to safer nicotine products.
Alan Gorley • Economics & Taxation • Australia
Community PerspectivesPolicy & Regulation
25 August 2026
Chapter One: Tobacco & Nicotine History That Contributes to the Regulatory Landscape
Skip Murray • Policy & Regulation • United States
Community PerspectivesPolicy & Regulation
22 August 2026
What Pop-Tarts cocktails reveal about the debate over flavored nicotine
Skip Murray • Policy & Regulation • United States
Community PerspectivesEconomics & Taxation
22 August 2026
Australia’s tobacco tax is collapsing, the illicit market is flourishing, and moral certainty is no substitute for policy that works.
Alan Gorley • Economics & Taxation • Australia
Community PerspectivesConsumer Perspectives
21 August 2026
I have spent a lot of time fighting.
Alan Gorley • Consumer Perspectives • Australia
Community PerspectivesRegional Perspectives
20 August 2026
For years, Australians have been told that the explosion of illicit tobacco and vaping is primarily an enforcement problem.
Alan Gorley • Regional Perspectives • Australia
Community PerspectivesMedia & Communications
19 August 2026
Getting the facts mostly right and the framing wrong
Kristof Redei • Media & Communications • USA
Community PerspectivesPolicy & Regulation
18 August 2026
One Nation has proposed a 75 per cent reduction in tobacco excise, and you could almost write the responses before they arrived: public health progress is threatened, Big Tobacco will benefit, smoking could increase, we need stronger enforcement, tougher penalties and more quitting support, and above all we must protect decades of tobacco control achievement.
Alan Gorley • Policy & Regulation • Australia
Community PerspectivesPublic Health Debate
17 August 2026
Lung Foundation Australia is right to demand equity in screening and care, but equity also requires an honest conversation about tobacco harm reduction.
Alan Gorley • Public Health Debate • Australia
Community PerspectivesConsumer Perspectives
14 August 2026
A great way to learn about other people's perspectives.
Skip Murray • Consumer Perspectives • United States
Community PerspectivesPublic Health Debate
14 August 2026
Tobacco causes immense harm. That does not excuse the use of selective evidence, false binaries and policy advocacy presented as neutral fact
Alan Gorley • Public Health Debate • Australia
Community PerspectivesMedia & Communications
12 August 2026
I’ve been sitting with the news that Filter is closing, trying to understand why it feels like such a personal loss.
Alan Gorley • Media & Communications • Australia
Community PerspectivesMedia & Communications
11 August 2026
No regrets
Skip Murray • Media & Communications • United States
Community PerspectivesPolicy & Regulation
10 August 2026
There is a sentence near the end of the ABC investigation into Australia’s illicit tobacco crisis that, for me, captures the central problem with the Australian debate.
Alan Gorley • Policy & Regulation • Australia
Community PerspectivesScience & Evidence
9 August 2026
Subject: To the Scientists Who Never Got the Memo
Alan Gorley • Science & Evidence • Australia
Community PerspectivesPolicy & Regulation
8 August 2026
When most people read the latest investigation into the collapse of the Australian Border Force’s secret intelligence unit, they will probably focus on one individual.
Alan Gorley • Policy & Regulation • Australia
Community PerspectivesCessation & Behaviour
6 August 2026
Working together towards the common goal - everyone wins
N. E. Loucas • Cessation & Behaviour • New Zealand
Community PerspectivesPolicy & Regulation
6 August 2026
Project Index
Skip Murray • Policy & Regulation • United States
Community PerspectivesConsumer Perspectives
5 August 2026
Ecological momentary assessment is an impressive research method because, instead of asking participants to reconstruct their behaviour days or weeks later, researchers contact them in real time to ask what they are doing, where they are, how they are feeling and what happened immediately before they vaped.
Alan Gorley • Consumer Perspectives • Australia
Community PerspectivesEthics & Human Rights
4 August 2026
We're failing people when we treat nicotine addiction and not the whole person
Skip Murray • Ethics & Human Rights • United States
Community PerspectivesCessation & Behaviour
3 August 2026
Every so often, a paper appears that calls for a “balanced perspective.” It is a phrase that sounds reassuring because science should be balanced, public policy should be balanced, and decisions that affect millions of lives should certainly be balanced.
Alan Gorley • Cessation & Behaviour • Australia
Community PerspectivesEthics & Human Rights
1 August 2026
Announcing the launch of a new page on the Safer Nicotine Wiki
Skip Murray • Ethics & Human Rights • United States
Community PerspectivesPolicy & Regulation
31 July 2026
Watching James Martin’s presentation alongside Cheneal Puljević’s is fascinating because they are not really arguing about whether Australia has an illicit tobacco crisis.
Alan Gorley • Policy & Regulation • Australia
Community PerspectivesConsumer Perspectives
30 July 2026
Imagine writing the history of civilisation not through kings, wars, borders, revolutions or empires, but through something much simpler: the history of safer.
Alan Gorley • Consumer Perspectives • Australia
Community PerspectivesConsumer Perspectives
29 July 2026
Simon’s latest argument is revealing because, underneath all the rhetoric, he actually concedes much of the problem his critics are describing.
Alan Gorley • Consumer Perspectives • Australia
Community PerspectivesProducts & Innovation
29 July 2026
There is a convenient story often told about tobacco harm reduction.
Alan Gorley • Products & Innovation • Australia
Community PerspectivesConsumer Perspectives
29 July 2026
Wherever my 10th grade English teacher, Mr. Loeffler is, I am sure he is smiling because someone was actually paying attention in class. ;-)
N. E. Loucas • Consumer Perspectives • New Zealand
Community PerspectivesConsumer Perspectives
29 July 2026
Evidence that patience, stories, and science really can change minds
Skip Murray • Consumer Perspectives • United States
Community PerspectivesScience & Evidence
28 July 2026
Review of 7 emblematic studies
Roberto Sussman • Science & Evidence • Mexico
Community PerspectivesScience & Evidence
26 July 2026
Review of 7 emblematic studies
Roberto Sussman • Science & Evidence • Mexico
Community PerspectivesConsumer Perspectives
26 July 2026
Every day we ask questions.
Alan Gorley • Consumer Perspectives • Australia
Community PerspectivesPolicy & Regulation
25 July 2026
Australia’s illicit tobacco crisis has reached a remarkable point.
Alan Gorley • Policy & Regulation • Australia
Community PerspectivesScience & Evidence
24 July 2026
From my GFN presentation in a panel titled "Debunking the Science Used to Support Prohibition"
Arielle Selya • Science & Evidence • US
Community PerspectivesScience & Evidence
23 July 2026
The science vs the politics
Roberto Sussman • Science & Evidence • Mexico
Community PerspectivesRegional Perspectives
22 July 2026
There are moments in public policy when the conversation itself becomes more important than the conclusions.
Alan Gorley • Regional Perspectives • Australia
Community PerspectivesConsumer Perspectives
19 July 2026
Lately, I have found myself thinking less about winning the battles in front of me and more about what will remain when those battles are no longer mine to fight.
Alan Gorley • Consumer Perspectives • Australia
Community PerspectivesScience & Evidence
17 July 2026
The latest National Drug Strategy Household Survey should have been an opportunity to give Australians a clear and honest account of what has happened to smoking, vaping and nicotine use since the federal government overturned the legal vaping market and forced lawful supply into participating pharmacies.
Alan Gorley • Science & Evidence • Australia
Community PerspectivesScience & Evidence
16 July 2026
From my GFN presentation in a panel titled "Debunking the Science Used to Support Prohibition"
Arielle Selya • Science & Evidence • US
Community PerspectivesConsumer Perspectives
15 July 2026
One of political economy’s most revealing ideas is the Bootleggers and Baptists paradox.
Alan Gorley • Consumer Perspectives • Australia
Community PerspectivesScience & Evidence
14 July 2026
Fitness studies looking for effects of vaping and smoking
Skip Murray • Science & Evidence • United States
Community PerspectivesConsumer Perspectives
12 July 2026
This is the final instalment of the series and continues directly from Part 2.
Alan Gorley • Consumer Perspectives • Australia
Community PerspectivesConsumer Perspectives
11 July 2026
This Substack continues from Part 1, where I explored how institutional incentives, path dependence and organisational structures can shape public policy.
Alan Gorley • Consumer Perspectives • Australia
Community PerspectivesEthics & Human Rights
10 July 2026
Adapted from my GFN 2026 presentation
Arielle Selya • Ethics & Human Rights • US
Community PerspectivesConsumer Perspectives
10 July 2026
Public health debates are often presented as contests between evidence and vested interests.
Alan Gorley • Consumer Perspectives • Australia
Community PerspectivesMedia & Communications
9 July 2026
July 9, 2026
Skip Murray • Media & Communications • United States
Community PerspectivesConsumer Perspectives
9 July 2026
July 8, 2026
Skip Murray • Consumer Perspectives • United States
Community PerspectivesConsumer Perspectives
8 July 2026
Honor Their Personal Agency
N. E. Loucas • Consumer Perspectives • New Zealand
Community PerspectivesConsumer Perspectives
6 July 2026
What effective altruists can learn from harm reduction's skepticism of paternalism
Kristof Redei • Consumer Perspectives • USA
Community PerspectivesScience & Evidence
4 July 2026
A Look at NHS England
Skip Murray • Science & Evidence • United States
Community PerspectivesPolicy & Regulation
3 July 2026
The US FDA CTP announcement was made June 30, 2026.
Skip Murray • Policy & Regulation • United States
Community PerspectivesPublic Health Debate
3 July 2026
My take on an exchange about Beaglehole et al.'s article showing a sudden steeper decline in New Zealand's smoking rate. Below, I expand my PubPeer comment on a published criticism to this article.
Arielle Selya • Public Health Debate • US
Community PerspectivesEthics & Human Rights
29 June 2026
Yet when it comes to nicotine and safer alternatives to smoking, that arc is bending in a strange direction.
N. E. Loucas • Ethics & Human Rights • New Zealand
Community PerspectivesConsumer Perspectives
25 June 2026
Where lives are at stake, it is imperative to identify common ground and pursue coordinated, evidence-based action.
N. E. Loucas • Consumer Perspectives • New Zealand
Community PerspectivesScience & Evidence
25 June 2026
My new paper shows that US adults are in the midst of switching from combustible cigarettes to e-cigarette use, with little dual use. Many other countries show similar transitions.
Arielle Selya • Science & Evidence • US
Community PerspectivesPublic Health Debate
23 June 2026
"Public health policies should encourage smokers to move away from combustible tobacco, not make safer alternatives inaccessible while cigarettes remain widely available."
N. E. Loucas • Public Health Debate • New Zealand
Community PerspectivesPublic Health Debate
23 June 2026
Why Tobacco Harm Reduction is a Policy Imperative in Asia Pacific
N. E. Loucas • Public Health Debate • New Zealand
Community PerspectivesScience & Evidence
18 June 2026
A look at Cleveland Clinic
Skip Murray • Science & Evidence • United States
Community PerspectivesPolicy & Regulation
14 June 2026
Laura Leigh Oyler (Haypp Group) and I discuss the history and current events of US regulation of nicotine and tobacco products.
Arielle Selya • Policy & Regulation • US
Community PerspectivesScience & Evidence
13 June 2026
A look at University of Iowa Health Care
Skip Murray • Science & Evidence • United States
Community PerspectivesEthics & Human Rights
7 June 2026
Recognising gender as a core risk factor is not about blaming individuals. It is about being honest that social norms, economic structures, and health systems are not neutral.
N. E. Loucas • Ethics & Human Rights • New Zealand
Community PerspectivesScience & Evidence
3 June 2026
Why do public health principles so often stop when the substance is nicotine?
Skip Murray • Science & Evidence • United States
Community PerspectivesConsumer Perspectives
1 June 2026
#OurVoices
Skip Murray • Consumer Perspectives • United States
Community PerspectivesScience & Evidence
31 May 2026
Correcting a flawed risk analysis
Roberto Sussman • Science & Evidence • Mexico
Community PerspectivesConsumer Perspectives
30 May 2026
What are we doing to our kids?
Skip Murray • Consumer Perspectives • United States
Community PerspectivesScience & Evidence
29 May 2026
Correcting a flawed risk analysis
Roberto Sussman • Science & Evidence • Mexico
Community PerspectivesMedia & Communications
27 May 2026
15th Annual World Vape Day - May 30, 2026
Skip Murray • Media & Communications • United States
Community PerspectivesMedia & Communications
25 May 2026
Guest post by Kurt Yeo
Skip Murray • Media & Communications • United States
Community PerspectivesScience & Evidence
25 May 2026
Summary of a useless research
Roberto Sussman • Science & Evidence • Mexico
Community PerspectivesRegional Perspectives
24 May 2026
A Policy Analysis | May 2026
N. E. Loucas • Regional Perspectives • New Zealand
Community PerspectivesPublic Health Debate
22 May 2026
Harm reduction is one of the most widely used yet poorly understood concepts in public life.
N. E. Loucas • Public Health Debate • New Zealand
Community PerspectivesScience & Evidence
4 May 2026
These are the trains of thought going through my head when I receive peer review invitations. Other scientists, what do you do?
Arielle Selya • Science & Evidence • US
Community PerspectivesScience & Evidence
24 April 2026
With wider acceptance that e-cigarettes are a viable harm-reduction method among people who smoke, the scientific battleground has retreated to "dual use." A recent exchange captures this well.
Arielle Selya • Science & Evidence • US
Community PerspectivesPolicy & Regulation
21 April 2026
Smoke-Free Reality vs Treaty Dogma: The Real Cost of The WHO FCTC Approach to Harm Reduction.
N. E. Loucas • Policy & Regulation • New Zealand
Community PerspectivesPublic Health Debate
21 April 2026
How false narratives about vaping and cancer risk are costing lives, and what we all must do about it.
N. E. Loucas • Public Health Debate • New Zealand
Community PerspectivesRegional Perspectives
12 April 2026
The real question was never whether THR sounds promising. It is whether governments can introduce it in a way that genuinely reduces harm without creating new problems.
N. E. Loucas • Regional Perspectives • New Zealand
Community PerspectivesScience & Evidence
9 April 2026
The report deals with vaping in a short review based on selective references to highlight risks
Roberto Sussman • Science & Evidence • Mexico
Community PerspectivesScience & Evidence
8 April 2026
Copied below is an email that my collaborators and I sent to journal editors expressing concern about a recent paper claiming a link between e-cigarette use and chronic kidney disease
Arielle Selya • Science & Evidence • US
Community PerspectivesScience & Evidence
6 April 2026
Part II. The case for/against Third Hand Vaping
Roberto Sussman • Science & Evidence • Mexico
Community PerspectivesConsumer Perspectives
31 March 2026
On Endurance, Stoicism and Learning What Not to Carry
N. E. Loucas • Consumer Perspectives • New Zealand
Community PerspectivesPublic Health Debate
31 March 2026
Why Effective THR Advocacy Starts With Meeting People Where They Are
N. E. Loucas • Public Health Debate • New Zealand
Community PerspectivesPolicy & Regulation
23 March 2026
Five reasons why a prescription-only model is problematic (video & text)
Arielle Selya • Policy & Regulation • US
Community PerspectivesConsumer Perspectives
18 March 2026
Why Some Former Opponents of Harm Reduction Shift Late in Their Careers
N. E. Loucas • Consumer Perspectives • New Zealand
Community PerspectivesConsumer Perspectives
17 March 2026
We are living in a moment where trust in health systems, institutions, and expertise is under pressure.
N. E. Loucas • Consumer Perspectives • New Zealand
Community PerspectivesScience & Evidence
16 March 2026
Part 2.
Roberto Sussman • Science & Evidence • Mexico
Community PerspectivesScience & Evidence
12 March 2026
Highlights, lowlights, and other notable things from the conference. Not meant to be an all-inclusive list or a representative summary; just what stood out to me personally.
Arielle Selya • Science & Evidence • US
Community PerspectivesEthics & Human Rights
10 March 2026
There is something deeply wrong when people feel they have to fight to be treated like human beings in conversations about their own health.
N. E. Loucas • Ethics & Human Rights • New Zealand
Community PerspectivesScience & Evidence
8 March 2026
Part II: Review of the literature on environmental vape aerosols.
Roberto Sussman • Science & Evidence • Mexico
Community PerspectivesEthics & Human Rights
5 March 2026
It goes beyond tobacco taxes/excise and political aspirations...way beyond.
N. E. Loucas • Ethics & Human Rights • New Zealand
Community PerspectivesScience & Evidence
21 February 2026
A highly-criticized meta-analysis of e-cigs &health outcomes was just updated. Not only does it still perpetuate critical flaws in the underlying studies, but it's interpreted with double-standards.
Arielle Selya • Science & Evidence • US
Community PerspectivesScience & Evidence
18 February 2026
Part I: Historical background on passive smoking.
Roberto Sussman • Science & Evidence • Mexico
Community PerspectivesScience & Evidence
14 February 2026
In my weekly review of new nicotine/tobacco research, I just saw two examples of a critical flaw that to my knowledge is a brand new error. (The two papers have a common author.)
Arielle Selya • Science & Evidence • US
Community PerspectivesScience & Evidence
26 January 2026
Efforts to correct flawed science often go nowhere, but there are a few recent successes: a couple post-publication criticisms and a retraction - though not before flawed papers had caused real damage
Arielle Selya • Science & Evidence • US
Community PerspectivesMedia & Communications
16 January 2026
I’ve decided to create a personal YouTube channel as part of a New Year’s resolution to bring THR science more widely to the public.
Arielle Selya • Media & Communications • US
Community PerspectivesScience & Evidence
7 January 2026
How I went from academic tobacco control researcher to industry consultant after changing my mind with my own analyses
Arielle Selya • Science & Evidence • US
Community PerspectivesPolicy & Regulation
28 December 2025
Observational behavioral studies cannot inform about causality, let alone make recommendations about effective policy. Yet many such logical leaps routinely get through peer review.
Arielle Selya • Policy & Regulation • US
Community PerspectivesEthics & Human Rights
20 December 2025
Lifestyle-related behaviors are important determinants of health — but excessive focus on potential risks is undermining people's autonomy to make the most basic decisions on their own.
Arielle Selya • Ethics & Human Rights • US
Community PerspectivesScience & Evidence
9 November 2025
The near-exclusive focus on extrinsic (and ignoring of intrinsic) drivers of behavior
Arielle Selya • Science & Evidence • US
Community PerspectivesScience & Evidence
3 November 2025
How it can improve research integrity, where it can go wrong, and how to do it right
Arielle Selya • Science & Evidence • US
Community PerspectivesScience & Evidence
19 September 2025
This is the tenth Substack post. It is the third one of a series of 3 posts dealing with environmental vape aerosols. A 4th post reviewing the literature is forecoming.
Roberto Sussman • Science & Evidence • Mexico
Community PerspectivesScience & Evidence
25 August 2025
This is the ninth Substack post. It is the second one of a series of 3 posts dealing with environmental vape aerosols.
Roberto Sussman • Science & Evidence • Mexico
Community PerspectivesScience & Evidence
4 August 2025
This is the eigth Substack post. It is the first one of a series of 3 posts dealing with environmental vape aerosols.
Roberto Sussman • Science & Evidence • Mexico
Community PerspectivesConsumer Perspectives
31 July 2025
What EA and harm reduction can learn from each other
Kristof Redei • Consumer Perspectives • USA
Community PerspectivesScience & Evidence
24 July 2025
A review of 40 studies
Roberto Sussman • Science & Evidence • Mexico
Community PerspectivesPublic Health Debate
22 July 2025
Widespread misperceptions are the norm across the world
Kristof Redei • Public Health Debate • USA
Community PerspectivesScience & Evidence
11 July 2025
Aldehydes, reactions, yields, comparisons with tobacco smoke & air pollution. Free radicals and carbon monoxide
Roberto Sussman • Science & Evidence • Mexico
Community PerspectivesScience & Evidence
2 July 2025
Examining the quit rates with a variety of methods
Kristof Redei • Science & Evidence • USA
Community PerspectivesScience & Evidence
26 April 2025
Summary
Roberto Sussman • Science & Evidence • Mexico
Community PerspectivesScience & Evidence
15 April 2025
Counting the DALYs in a can of snus
Kristof Redei • Science & Evidence • USA
Community PerspectivesScience & Evidence
6 April 2025
Testing vapes in the laboratory
Roberto Sussman • Science & Evidence • Mexico
Community PerspectivesConsumer Perspectives
28 January 2025
What makes THR THR?
Kristof Redei • Consumer Perspectives • USA